Cite

HARVARD Citation

    Geiger, J. et al. (2016). Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma. Head & neck. 38 (12), pp. 1759-1764. [Online]. 
  
Back to record